Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

Numinus Provides Bi-Weekly Update on Annual Filings
VANCOUVER, BC , Jan. 13, 2025 /PRNewswire/ - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a leader in mental health care specializing in innovative and evidence-based treatments, today provided an update with respect to its previously announced management cease trade order ("MCTO") in connection with the Company's filing of its audited annual financial statements (the "Audited Financial Statements"), management discussion and analysis (the "MD&A"), and annual information form (the "AIF") for the financial year ended August 31, 2024 and the applicable CEO and CFO certifications (together with the Audited Financial Statements, the MD&A, and the AIF, the "Annual Filings"). Further to the Company's news release dated December 3, 2024 (the "Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "Commission"), granted the MCTO on December 2, 2024, under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203").» Mehr auf prnewswire.com
Numinus Provides Bi-Weekly Update on Annual Filings
VANCOUVER, BC , Jan. 1, 2025 /PRNewswire/ - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a leader in mental health care specializing in innovative and evidence-based treatments, today provided an update with respect to its previously announced management cease trade order ("MCTO") in connection with the Company's filing of its audited annual financial statements (the "Audited Financial Statements"), management discussion and analysis (the "MD&A"), and annual information form (the "AIF") for the financial year ended August 31, 2024 and the applicable CEO and CFO certifications (together with the Audited Financial Statements, the MD&A, and the AIF, the "Annual Filings"). Further to the Company's news release dated December 3, 2024 (the "Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "Commission"), granted the MCTO on December 2, 2024, under National Policy 12-203 – Management Cease Trader Orders ("NP 12-203").» Mehr auf prnewswire.com
Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care
U.S. wellness clinics sold to Stella, including a data-sharing partnership to launch a technology-driven clinic management solution for mental health care providers. Numinus Wellness clinics acquired by Stella for US$3.53 million Numinus focusing on business units and product development ("Numinus Network") to facilitate clinic efficiency and care reimbursement for mental health practitioners Stella partnering with Numinus to share operational data from its network of 12 mental health clinics, supporting the development of advanced clinic management solutions for mental health practices, including insurance reimbursement support Creates an asset-light business with a synergistic combination of clinical support, practitioner training and clinical research with a strengthened balance sheet VANCOUVER, BC , Dec. 17, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces the closing of the previously announced definitive agreement with Stella, an interventional psychiatry practice focused on treating PTSD, anxiety and depression with biological modalities, of the sale of the Company's five Wellness Clinics in Utah for US$3.53 million.» Mehr auf prnewswire.com

Historische Dividenden

Alle Dividenden Kennzahlen

In 2022 hat Numinus Wellness 0,50€ Dividende ausgeschüttet. Die letzte Dividende wurde im Oktober 2022 gezahlt.

Unternehmenszahlen

Im letzten Quartal hatte Numinus Wellness einen Umsatz von 2,93 Mio€ und ein Nettoeinkommen von −3,88 Mio€

(EUR)	Mai 2024	YOY
Umsatz	+2,93 Mio	-
Bruttoeinkommen	+646,17k	-
Nettoeinkommen	−3,88 Mio	-
EBITDA	−3,08 Mio	-

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+10,00 Mio€
Anzahl Aktien	322,32 Mio
52 Wochen-Hoch/Tief	+0,12€ - +0,0165€
Dividenden	Nein
Beta	1,55
KGV (PE Ratio)	−0,47
KGWV (PEG Ratio)	−0,11
KBV (PB Ratio)	+2,59
KUV (PS Ratio)	+0,68

Unternehmensprofil

Numinus Wellness Inc. bietet Lösungen für die Entwicklung und Bereitstellung psychedelisch unterstützter Psychotherapien und für die Umgestaltung der psychischen Gesundheitslandschaft. Das Unternehmen ist in zwei Abteilungen tätig, Salvation Botanicals und Numinus Health. Die Abteilung Salvation Botanicals bietet Labordienstleistungen wie Anbau, analytische Tests, Produktforschung und -entwicklung sowie ergänzende Dienstleistungen im Bereich der Psychedelika an und führt umfassende Tests und kundenspezifische Tests von Cannabis durch. Die Abteilung Numinus Health bietet unterstützende Therapien und Technologien zur Heilung, Verbindung und zum Wachstum mit Schwerpunkt auf der Behandlung von psychischer Gesundheit und Drogenmissbrauch sowie Dienstleistungen für Psychotherapie, Beratung, Neurofeedback, Physiotherapie und andere Therapien. Dieser Geschäftsbereich bietet auch Schulungen, Einrichtungen und andere operative Ressourcen für Therapeuten an. Der Hauptsitz des Unternehmens befindet sich in Vancouver, Kanada.